THE STATE OF THE ART OF KEFIR APPLICATIONS AS ADJUNCTIVE THERAPY IN CENTRAL NERVOUS SYSTEM DISEASES

Read full text Summarise with VIRAT
Authors: Danielly Herbst Pereira, Lucas Sereno Langa Moura, Maria Eduarda Lopes Mota, Maria Eduarda Mateini, Mikaela de Jesus Mullin, Milena Cunha Falcão, Vanêssa Bassini Mesquita, João Victor De Sousa Coutinho
Cited by: 0
References: 49

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The central nervous system (CNS) is affected by several neurodegenerative, psychiatric, and neuroinflammatory disorders, for which conventional therapies still present limitations related to efficacy, safety, and cost. In this context, kefir has been investigated as a potential adjunctive therapy due to its ability to modulate the gut–brain axis. This study aimed to review the state of the art of kefir applications in CNS diseases, focusing on its bioactive compounds, mechanisms of action, and preclinical and clinical evidence. This narrative review was based on searches in major scientific databases, including studies published over the last 15 years. Kefir has a complex microbial composition consisting of lactic acid bacteria, acetic acid bacteria, and yeasts capable of producing kefiran, bioactive peptides, organic acids, free amino acids, and short-chain fatty acids. The available evidence indicates effects on intestinal and blood–brain barrier integrity, inflammatory modulation, tryptophan metabolism, neurotransmitter production, and oxidative stress reduction. Promising findings were observed particularly in depression, epilepsy, and Alzheimer’s disease. However, methodological limitations and the scarcity of robust clinical trials still prevent definitive conclusions regarding its clinical application.

Fields of Study & Subjects

Probiotics and Fermented Foods Gut microbiota and health Protein Hydrolysis and Bioactive Peptides

Publication details

Journal / source
International Journal of Health Management Review
Volume
12
Issue
1
Pages
e468–e468
Publication date
27 March 2026
Language
EN